Template:Lipoprotein disorders: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 148: Line 148:
!
!


|- bgcolor="CornFlowerBlue"
|- bgcolor="CadetBlue"
!
!
Treatment
Treatment
Line 154: Line 154:
!
!


|- bgcolor="Pale Turquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Lipoprotein disorders medical therapy|Medical Therapy]]
[[Lipoprotein disorders medical therapy|Medical Therapy]]
Line 160: Line 160:
!
!


|- bgcolor="Pale Turquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Lipoprotein disorders surgery|Surgery]]
[[Lipoprotein disorders surgery|Surgery]]
Line 166: Line 166:
!
!


|- bgcolor="Pale Turquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Lipoprotein disorders primary prevention|Primary Prevention]]
[[Lipoprotein disorders primary prevention|Primary Prevention]]
Line 172: Line 172:
!
!


|- bgcolor="Pale Turquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Lipoprotein disorders secondary prevention|Secondary Prevention]]
[[Lipoprotein disorders secondary prevention|Secondary Prevention]]
Line 178: Line 178:
!
!


|- bgcolor="Pale Turquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Lipoprotein disorders cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
[[Lipoprotein disorders cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
Line 184: Line 184:
!
!


|- bgcolor="Pale Turquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Lipoprotein disorders future or investigational therapies|Future or Investigational Therapies]]
[[Lipoprotein disorders future or investigational therapies|Future or Investigational Therapies]]
Line 190: Line 190:
!
!


|- bgcolor="CornFlowerBlue"
|- bgcolor="CadetBlue"
!
!
Case Studies
Case Studies
Line 196: Line 196:
!
!


|- bgcolor="Pale Turquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Lipoprotein disorders case study one|Case #1]]
[[Lipoprotein disorders case study one|Case #1]]

Revision as of 18:09, 21 July 2016